Loading…
Reported covered position: Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Combating Organized Retail Crime Act of 2025
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
General Issues Related to report language regarding paper inserts H.R. 2853, Combating Organized Retail Crime Act Education around issues facing pharmacies, including Main Street Pharmacy Access Act (H.R. 3164)
Combating Organized Retail Crime Act of 2025
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TOLMAR INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Source: Senate LDA
| OPTION CARE HEALTH |
| 16 |
| 2023–2026 |
| PHRMA | 16 | 2023–2026 |
| QUEST DIAGNOSTICS | 16 | 2023–2026 |
| SAREPTA THERAPEUTICS | 16 | 2023–2026 |
| VERTEX PHARMACEUTICALS INCORPORATED | 16 | 2023–2026 |
| ABBOTT (FORMERLY KNOWN AS ALERE INC.) | 15 | 2023–2026 |
| ABBVIE, INC. | 15 | 2023–2026 |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) | 15 | 2023–2026 |
| AMERICAN OSTEOPATHIC ASSOCIATION | 15 | 2023–2026 |
| AMGEN, INC. | 15 | 2023–2026 |
| AMYLYX PHARMACEUTICALS | 15 | 2023–2026 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 15 | 2023–2026 |
| BOEHRINGER INGELHEIM | 15 | 2023–2026 |
| CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | 15 | 2023–2026 |
| ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) | 15 | 2023–2026 |
| ELI LILLY AND COMPANY | 15 | 2023–2026 |
| FOUNDATION MEDICINE | 15 | 2023–2026 |
| GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) | 15 | 2023–2026 |
| GILEAD SCIENCES, INC. | 15 | 2023–2026 |
| LONGEVITY HEALTH PLAN | 15 | 2023–2026 |
| MERCK | 15 | 2023–2026 |
| NOVO NORDISK, INC. | 15 | 2023–2026 |
| SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) | 15 | 2023–2026 |
| THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) | 15 | 2023–2026 |
| AMAZON.COM SERVICES LLC | 14 | 2024–2026 |
| BRISTOL MYERS SQUIBB | 14 | 2023–2026 |
| EXCELLUS HEALTH PLAN INC. | 14 | 2023–2026 |
| ACCENTURE FEDERAL SERVICES | 13 | 2023–2026 |
| BD (BECTON, DICKINSON AND COMPANY) | 13 | 2023–2026 |
| LANTHEUS | 13 | 2024–2026 |
| THE AMPUTEE COALITION | 13 | 2023–2026 |
| ADVAMED | 12 | 2024–2026 |
| AMNEAL PHARMACEUTICALS, INC. | 12 | 2024–2026 |
| CRINETICS PHARMACEUTICALS | 12 | 2024–2026 |
| GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS) | 12 | 2023–2026 |
| HEALTH CARE SERVICE CORPORATION | 12 | 2023–2025 |
| AVAILITY | 11 | 2024–2026 |
| JAZZ PHARMACEUTICALS INC. | 11 | 2023–2025 |
| NATIONAL SEATING & MOBILITY | 11 | 2024–2026 |
| SAS | 11 | 2023–2025 |
| BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) | 10 | 2023–2024 |
| AMERICAN ACADEMY OF HOME CARE MEDICINE | 9 | 2025–2026 |
| ASTELLAS PHARMA US, INC. | 9 | 2024–2026 |
| VALNEVA USA, INC | 9 | 2023–2024 |
| AIS HEALTHCARE | 8 | 2023–2024 |
| FLAGSHIP PIONEERING | 8 | 2023–2024 |
| LINCARE | 8 | 2023–2024 |
| MATHEMATICA INC. | 8 | 2025–2026 |
| NOVOCURE INC. | 8 | 2023–2024 |
| PHREESIA | 8 | 2025–2026 |
| PRIORITY ON DEMAND | 8 | 2025–2026 |
| TRIPLE-S MANAGEMENT CORPORATION | 8 | 2023–2024 |
| AMERICAN COLLEGE OF PHYSICIANS | 7 | 2025–2026 |
| NATIONAL ASSOCIATION OF ACCOUNTABLE CARE ORGANIZATIONS | 7 | 2025–2026 |
| HANSA BIOPHARMA | 6 | 2024–2025 |
| MEDICALLY HOME | 6 | 2023–2024 |
| OCTAVIANT FINANCIAL INC. | 6 | 2023–2024 |
| ADVOCATES FOR COMMUNITY HEALTH | 5 | 2023 |
| CALIFORNIA PROTONS CANCER THERAPY CENTER | 5 | 2025–2026 |
| EVERGREEN NEPHROLOGY | 5 | 2024 |
| HEALTH GORILLA | 5 | 2023 |
| RAYNER SURGICAL INC. | 5 | 2026 |
| SPARX GROUP INC. | 5 | 2025 |
| 10X GENOMICS | 4 | 2023 |
| CHAPTER | 4 | 2026 |
| HEALTHCARE LEADERSHIP COUNCIL | 4 | 2023 |
| Hims & Hers Health, Inc. | 4 | 2023–2024 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (MITA) | 4 | 2023 |
| NEUROCRINE BIOSCIENCES, INC | 4 | 2023 |
| ONE MEDICAL | 4 | 2023 |
| SWORD HEALTH, INC. | 4 | 2025–2026 |
| AMERICAN INVESTMENT COUNCIL | 2 | 2023 |
| BIG HEALTH, INC. | 2 | 2026 |
| FRESENIUS MEDICAL CARE | 2 | 2026 |
| TOLMAR INC. | 2 | 2026 |
General Issues Related to report language regarding paper inserts H.R. 2853, Combating Organized Retail Crime Act
Ensuring Community Access to Pharmacist Services Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
General Issues Related to report language regarding paper inserts H.R. 2853, Combating Organized Retail Crime Act Education around issues facing pharmacies, including Main Street Pharmacy Access Act (H.R. 3164)
Health Care Cybersecurity and Resiliency Act of 2026
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule Education around issues facing independent physicians, including S. 3822, the Break Up Big Medicine Act S.3315 and House draft, Healthcare Cybersecurity and Resiliency Act
Break Up Big Medicine Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule Education around issues facing independent physicians, including S. 3822, the Break Up Big Medicine Act S.3315 and House draft, Healthcare Cybersecurity and Resiliency Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; S 891 Bipartisan Healthcare Act; HR 1968 Full Year Continuing Appropriations and Extensions Act of 2025, PL 119-4.
Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)
Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)
Bipartisan Health Care Act
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; S 891 Bipartisan Healthcare Act; HR 1968 Full Year Continuing Appropriations and Extensions Act of 2025, PL 119-4.
American Relief Act, 2025
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 8467 - Farm, Food, and National Security Act of 2024 H.R. 10545 - American Relief Act of 2025 Drug safety, prescription drug abuse, value of prescription drugs
American Relief Act, 2025
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
Medicare reimbursement issues, S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
Medicare reimbursement issues, S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
Medicare reimbursement issues, Medicare payment for radiopharmaceuticals S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
Medicare reimbursement issues, S. 1544/H.R.1199 FIND Act
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: LANTHEUS · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 1544/H.R.1199 FIND Act
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act (AKAC) S. 3234, Chronic Disease Flexible Coverage Act
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Further Consolidated Appropriations Act, 2024
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4336, the Consolidated Appropriations Act, 2024 (P.L. 118-42) H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) Drug safety, prescription drug abuse, value of prescription drugs, expiring healthcare extenders
Charitable Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
SCREENS for Cancer Act of 2024
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3916/S.1840 - SCREENS for Cancer Act of 2023 IRA implementation, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
SCREENS for Cancer Act of 2024
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3916/S.1840 - SCREENS for Cancer Act of 2023 IRA implementation, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preserving Patient Access to Home Infusion Act
Client: OPTION CARE HEALTH · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Preserving Patient Access to Home Infusion Act
Client: OPTION CARE HEALTH · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Summer Meals REACH Act of 2023
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4336, the Consolidated Appropriations Act, 2024 (P.L. 118-42) H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) Drug safety, prescription drug abuse, value of prescription drugs, expiring healthcare extenders
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Small Business Tax Fairness and Compliance Simplification Act
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.45 - Small Business Tax Fairness and Compliance Simplification Act IRA implementation, patient engagement, alternative payment models
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act (AKAC) S. 3234, Chronic Disease Flexible Coverage Act
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Protecting Health Care for All Patients Act of 2023
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
Protecting Health Care for All Patients Act of 2023
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
Lower Costs, More Transparency Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
Implementation of the special diabetes program, renewal of the special diabetes program, artificial pancreas program, NIH, innovation in drug development for diabetes, insulin access and affordability H.R. 5378 Lower Costs, More Transparency Act S. 1269 - INSULIN Act of 2023 S. 1855 Special Diabetes Program Reauthorization Act of 2023
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation, FY25 appropriations
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act Prescription drug access and affordability, pricing, transparency, biosimilars, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
lobbying related to medicare policy, ESRD
Filing targets: Centers For Medicare and Medicaid Services (CMS)
BIG HEALTH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Improving Medicare payment for digital metal health treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
TOLMAR INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · RR
Medicare policy
FRESENIUS MEDICAL CARE via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · RR
lobbying related to medicare policy, ESRD
BIG HEALTH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · RR
Improving Medicare payment for digital metal health treatment
VERTEX PHARMACEUTICALS INCORPORATED via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical and Medicare/Medicaid policy
Lobbying related to pharmaceutical policy
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to health care policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
federal budget issues
Lobbying related to rare disease policy and coverage
Lobbying related to rare disease policy
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical policy
federal budget issues
Lobbying related to pharmaceutical policy and Medicare coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAYNER SURGICAL INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare payment policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to diagnostics and Medicare reimbursement policy.
Lobbying related to diagnostics and Medicare reimbursement policy.
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIORITY ON DEMAND via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicaid and Medicare and health care coverage policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHRMA via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical and Medicare & Medicaid policy
Lobbying related to pharmaceutical policy
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
patient engagement, health care technology
Medicare innovation, patient engagement
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OPTION CARE HEALTH via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare coverage and payment
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical policy and access
Federal budget issues
Lobbying related to pharmaceutical policy and access
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to trade
Lobbying related to pharmaceutical policy
Federal budget issues
Lobbying related to pharmaceutical policy
NATIONAL SEATING & MOBILITY via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare coverage and reimbursement policy
Lobbying related to Medicare coverage and reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF ACCOUNTABLE CARE ORGANIZATIONS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare payment and delivery reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MERCK via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Federal budget issues
IRA, innovation, drug pricing in federal programs, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA
IRA, Medicare and Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MATHEMATICA, INC via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · 3T
Lobbying related to health care data and program integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
LONGEVITY HEALTH PLAN via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare Advantage and managed care policy
Lobbying related to Medicare Advantage and managed care policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LANTHEUS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
General Issues Related to report language regarding paper inserts H.R. 2853, Combating Organized Retail Crime Act Education around issues facing pharmacies, including Main Street Pharmacy Access Act (H.R. 3164)
General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule Education around issues facing independent physicians, including S. 3822, the Break Up Big Medicine Act S.3315 and House draft, Healthcare Cybersecurity and Resiliency Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
GILEAD SCIENCES, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical policy
Lobbying related to pharmaceutical policy
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to hospice care policy.
Lobbying related to hospice care policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare & Medicaid and pharmaceutical policy
Federal budget issues
Lobbying related to pharmaceutical policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOUNDATION MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to diagnostics and health care policy.
Lobbying related to diagnostics and health care policy and payment issues
supply chain
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
ELI LILLY AND COMPANY via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical policy
federal budget issues
Medicare & Medicaid payment and coverage issues, lobbying related to pharmaceutical policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXCELLUS HEALTH PLAN, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Medicare Advantage, Medicare reimbursement and payment issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Federal budget issues
Lobbying related to health care access, Medicare, and Medicaid policy
Lobbying related to health care access
CRINETICS PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · 3T
innovation, prescription drug pricing
Medicare policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHAPTER via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to health care coverage and technology policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical supply
Federal budget issues
lobbying related to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CALIFORNIA PROTONS CANCER THERAPY CENTER via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Medicare reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS)
BRISTOL MYERS SQUIBB via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical policy
Medicare & Medicaid payment and coverage issues
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare & Medicaid coverage and payment issues
federal budget issues
Lobbying related to pharmaceutical policy
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS BLUE SHIELD ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
federal budget issues
issues related to tax
Lobbying related to Medicare and Medicaid policy
BIOTECHNOLOGY INDUSTRY ORGANIZATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical and health care policy and Medicare & Medicaid payment and coverage issues
Federal budget issues
Lobbying related to pharmaceutical, tax, and health care policy
ALZHEIMER'S ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Medicare & Medicaid coverage and reimbursement issues
Lobbying related to health care policy and research funding
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALZHEIMER'S ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to health care policy and research funding
federal budget issues
Medicare & Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVAILITY via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to health care technology and program integrity.
Lobbying related to health care technology and program integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMYLYX PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
rare disease and access to innovation
rare disease and access to innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMNEAL PHARMACEUTICALS, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
federal budget issues
Lobbying related to domestic pharmaceutical supply
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical policy and Medicare policy
federal budget issues
Lobbying related to pharmaceutical policy and health care access
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OSTEOPATHIC ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to physician payment and workforce
federal budget issues
Lobbying related to physician payment and workforce
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to pharmaceutical policy and Medicare and Medicaid policy
federal budget issues
Lobbying related to pharmaceutical policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF PHYSICIANS via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to physician payment, health care access, and public health policy
Lobbying related to physician payment and health care access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to health care policy, access, and coverage
federal budget issues
Lobbying related to health care policy, access and coverage, and Medicare & Medicaid policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ACADEMY OF HOME CARE MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to Medicare payment and home-based care policy
Lobbying related to Medicare payment and home-based care policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMAZON.COM SERVICES LLC via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
federal budget issues
Lobbying related to health care policy, technology, and Medicare policy
Lobbying related to health care policy, technology, Medicare policy, and FDA policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVAMED via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
Lobbying related to medical device policy and Medicare reimbursement/coverage.
Lobbying related to medical device policy, innovation, technology policy, right to repair and Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT (FORMERLY KNOWN AS ALERE INC.) via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
issues related to national trade
Lobbying related to health care policy, Medicare reimbursement
Lobbying related to health care policy, Medicare reimbursement
ABBVIE INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · third_quarter · Q3
drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA
Part B, Part D, drug pricing and access, negotiation,
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MATHEMATICA, INC via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · 2A
Lobbying related to health care data and program integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERICAN ACADEMY OF HOME CARE MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · 2A
Lobbying related to Medicare payment and home-based care policy
Lobbying related to Medicare payment and home-based care policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
RAYNER SURGICAL INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · 2A
Lobbying related to Medicare payment policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical and health care policy
Lobbying related to pharmaceutical and health care policy and Medicare & Medicaid payment and coverage issues
Federal budget issues
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule General Issues Related to Supply Chain Ownership
General Issues Related to report language regarding paper inserts H.R. 2853, Combating Organized Retail Crime Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMAZON.COM SERVICES LLC via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
federal budget issues
Lobbying related to health care policy, technology, and Medicare policy
Lobbying related to health care policy, technology, Medicare policy, and FDA policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBVIE INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Part B, Part D, drug pricing and access, negotiation,
federal budget issues
drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MERCK via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
IRA, Medicare and Medicaid payment and coverage issues
Federal budget issues
IRA, innovation, drug pricing in federal programs, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical policy
Lobbying related to pharmaceutical policy
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Federal budget issues
Lobbying related to pharmaceutical policy
Lobbying related to pharmaceutical policy
CRINETICS PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
innovation, prescription drug pricing
Medicare policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to health care policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF HOME CARE MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicare payment and home-based care policy
Lobbying related to Medicare payment and home-based care policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF PHYSICIANS via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to physician payment and health care access
Lobbying related to physician payment, health care access, and public health policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALZHEIMER'S ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to health care policy and research funding
federal budget issues
Medicare & Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN OSTEOPATHIC ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to physician payment and workforce
Lobbying related to physician payment and workforce
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS BLUE SHIELD ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
issues related to tax
federal budget issues
Lobbying related to coverage, health insurance policy, and Medicare & Medicaid policy
BRISTOL MYERS SQUIBB via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical policy
federal budget issues
Medicare & Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to health care access, Medicare, and Medicaid policy
Lobbying related to health care access
Tax policy
NATIONAL ASSOCIATION OF ACCOUNTABLE CARE ORGANIZATIONS via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicare payment and delivery reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHRMA via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · 2A
Lobbying related to pharmaceutical and Medicare & Medicaid policy
Federal budget issues
Lobbying related to pharmaceutical policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTION CARE HEALTH via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicare coverage and payment
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHRMA via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical policy
Lobbying related to pharmaceutical and Medicare & Medicaid policy
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIORITY ON DEMAND via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicaid and health care coverage policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXCELLUS HEALTH PLAN, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Medicare Advantage, Medicare reimbursement and payment issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LANTHEUS via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicare reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Federal budget issues
Lobbying related to pharmaceutical policy and access
Lobbying related to pharmaceutical policy and access
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SAREPTA THERAPEUTICS via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to rare disease policy
Lobbying related to rare disease policy and coverage
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical policy
federal budget issues
Lobbying related to pharmaceutical policy and Medicare coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CALIFORNIA PROTONS CANCER THERAPY CENTER via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Medicare reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS)
RAYNER SURGICAL INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicare payment policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHREESIA via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Federal budget issues
Medicare innovation, patient engagement
patient engagement, health care technology
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL SEATING & MOBILITY via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicare coverage and reimbursement policy
Lobbying related to Medicare coverage and reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LONGEVITY HEALTH PLAN via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to Medicare Advantage and managed care policy
Lobbying related to Medicare Advantage and managed care policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Federal budget issues
Lobbying related to Medicare & Medicaid and pharmaceutical policy
Lobbying related to pharmaceutical policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Medicare & Medicaid payment and coverage issues, lobbying related to pharmaceutical policy
Lobbying related to pharmaceutical policy
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical supply
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical policy
Lobbying related to Medicare & Medicaid coverage and payment issues
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
federal budget issues
Lobbying related to pharmaceutical policy and Medicare and Medicaid policy
Lobbying related to pharmaceutical policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLYX PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
rare disease and access to innovation
rare disease and access to innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to pharmaceutical policy and Medicare policy
Lobbying related to pharmaceutical policy and health care access
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ADVAMED via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to medical device policy, innovation, and Medicare reimbursement.
Lobbying related to medical device policy and Medicare reimbursement/coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
federal budget issues
Lobbying related to health care policy, access and coverage, and Medicare & Medicaid policy
Lobbying related to health care policy, access, and coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT (FORMERLY KNOWN AS ALERE INC.) via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
federal budget issues
Lobbying related to health care policy, Medicare reimbursement
issues related to national trade
AMNEAL PHARMACEUTICALS, INC. via TARPLIN, DOWNS & YOUNG, LLC
2026 · second_quarter · Q2
Lobbying related to domestic pharmaceutical supply
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Lobbying related to health care access, Medicare, and Medicaid policy
Tax policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Lobbying related to coverage, health insurance policy, and Medicare & Medicaid policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
lobbying related to trade issues
Lobbying related to pharmaceutical and health care policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Lobbying related to pharmaceutical, tax, and health care policy
lobbying related to trade issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Lobbying related to trade
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Lobbying related to Medicare and Medicaid policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Federal budget issues
Lobbying related to health care access, Medicare, and Medicaid policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Lobbying related to health care policy, Medicare reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office